切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (02) : 142 -151. doi: 10.3877/cma.j.issn.1673-5250.2021.02.004

所属专题： 文献； 指南共识；

《巴西肿瘤外科协会盆腔廓清术治疗宫颈癌指南》解读
王一然, 王平†()   
  • 收稿日期:2020-10-07 修回日期:2021-02-15 出版日期:2021-04-01
  • 通信作者: 王平

Interpretation of the Guidelines of the Brazilian Society of Oncologic Surgery for Pelvic Exenteration in the Treatment of Cervical Cancer

Yiran Wang, Ping Wang†()   

  • Received:2020-10-07 Revised:2021-02-15 Published:2021-04-01
  • Corresponding author: Ping Wang
  • Supported by:
    Key Research and Development Project of Science and Technology Department in Sichuan Province(2018FZ0057)
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王一然, 王平. 《巴西肿瘤外科协会盆腔廓清术治疗宫颈癌指南》解读[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(02): 142-151.

Yiran Wang, Ping Wang. Interpretation of the Guidelines of the Brazilian Society of Oncologic Surgery for Pelvic Exenteration in the Treatment of Cervical Cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(02): 142-151.

2019年12月，巴西肿瘤外科协会(Brazilian Society of Surgical Oncology)针对放、化疗后局部持续或复发宫颈癌(PRCC)患者的补救性盆腔廓清术(PE)治疗，颁布《巴西肿瘤外科协会盆腔廓清术治疗宫颈癌指南》(Guidelines of the Brazilian Society of Oncologic Surgery for Pelvic Exenteration in the Treatment of Cervical Cancer)(以下简称为《PE指南》)。该指南基于目前文献中可获得最佳证据，对局部PRCC患者进行补救性PE的最佳处理方式提出建议。这是全球首次颁布的关于PE作为局部PRCC患者治疗选择的指南。笔者拟就该指南涉及的局部PRCC患者接受根治性或姑息性PE治疗的适应证、术前评估、术中评估，PE治疗手术入路及技巧、PE手术范围分类，PE患者尿路重建、阴道重建、肠道重建、盆底功能重建，以及PE术后患者随访等内容进行详细解读。

关键词: 宫颈肿瘤, 持续或复发宫颈癌, 盆腔廓清术, 肿瘤复发, 局部, 手术后并发症, 盆底功能重建, 修复外科手术, 女(雌)性

The Guidelines of the Brazilian Society of Oncologic Surgery for Pelvic Exenteration in the Treatment of Cervical Cancer (hereinafter referred to PE Guidelines) had been published in December 2019 for patients with locally persistent or recurrent cervical cancer (PRCC) after radiotherapy or chemotherapy. Recommendations for the best management of patients with locally PRCC undergoing salvage pelvic exenteration (PE) were developed and based on the best evidence available in literature. This is the first guideline or consensus on PE in the treatment of locally PRCC which has been proposed in the world. The research contents of PE Guidelines include indications for curative and palliative PE, preoperative and intraoperative evaluation, access routes and surgical techniques, PE classification, urinary, vaginal, intestinal, and pelvic floor reconstructions, and postoperative follow-ups, which will be interpreted in this article.

Key words: Uterine cervical neoplasms, Persistent or recurrent cervical cancer, Pelvic exenteration, Neoplasm recurrence, local, Postoperative complications, Pelvic floor reconstruction, Reconstructive surgical procedures, Female
表1 《PE指南》证据水平(质量)分级体系
证据水平(质量) 证据来源
Ⅰ 来源于≥1项方法学质量高(偏倚风险低)的针对局部PRCC患者PE的大型随机对照试验，或对进行良好、无异质性的针对局部PRCC患者PE的随机对照试验进行的Meta分析
Ⅱ 来源于针对局部PRCC患者PE的小规模随机对照试验，或方法学质量较低的针对局部PRCC患者PE的大型随机对照试验，或偏倚风险高的Meta分析
Ⅲ 来源于针对局部PRCC患者PE的前瞻性队列研究
Ⅳ 来源于针对局部PRCC患者PE的回顾性队列研究或病例对照研究
Ⅴ 来源于针对局部PRCC患者PE的病例报告和专家观点
表2 《PE指南》推荐级别(强度)分级体系
推荐级别(强度) 证据与强度
A 强烈建议：有力证据证明具有疗效和重大临床益处
B 一般建议：强或中度证据证明具有疗效，但是临床益处有限
C 可选：疗效证据不足，或临床益处不会超过风险或缺点
D 一般不推荐：中度证据证明无效或导致不良结果
E 不推荐：有力证据证明否定疗效或导致不良结果
表3 PE手术范围分类
手术范围 肛提肌以上切除 肛提肌以下切除
前PE 后PE 全PE 前PE 后PE 全PE
子宫/输卵管/卵巢 切除 切除 切除 切除 切除 切除
阴道 部分切除 部分切除 部分切除 切除 切除 切除
外阴 保留 保留 保留 术中评估后决定 保留 术中评估后决定
膀胱、尿道 切除 保留 切除 切除 保留 切除
直肠 保留 切除 切除 保留 切除 切除
肛门括约肌 保留 保留 保留 保留 切除 切除
[51]
Gavriilidis P, Azoulay D, Taflampas P. Loop transverse colostomy versus loop ileostomy for defunctioning of colorectal anastomosis: a systematic review, updated conventional Meta-analysis, and cumulative Meta-analysis[J]. Surg Today，2019，49(2)：108-117. DOI: 10.1007/s00595-018-1708-x.
[52]
Abdou AH, Li L, Khatib-Chahidi K, et al. Free latissimus dorsi myocutaneous flap for pelvic floor reconstruction following pelvic exenteration[J]. Int J Colorectal Dis，2016，31(2)：385-391. DOI：10.1007/s00384-015-2402-8.
[53]
Mericli AF, Martin JP, Campbell CA. An algorithmic anatomical subunit approach to pelvic wound reconstruction[J]. Plast Reconstr Surg，2016，137(3)：1004-1017. DOI: 10.1097/01.prs.0000479973.45051.b6.
[54]
Miyamoto Y, Akiyama T, Sakamoto Y, et al. Omental flap after pelvic exenteration for pelvic cancer[J]. Surg Today，2016，46(12)：1471-1475. DOI: 10.1007/s00595-016-1348-y.
[55]
Devulapalli C, Jia Wei AT, Dibiagio JR, et al. Primary versus flap closure of perineal defects following oncologic resection[J]. Plast Reconstr Surg，2016，137(5)：1602-1613. DOI: 10.1097/PRS.0000000000002107.
[56]
Sheckter CC, Shakir A, Vo H, et al. Reconstruction following abdominoperineal resection (APR): indications and complications from a single institution experience[J]. J Plast Reconstr Aesthet Surg，2016，69(11)：1506-1512. DOI: 10.1016/j.bjps.2016.06.024.
[57]
Sbarra M, Miccò M, Corvino M, et al. CT findings after pelvic exenteration: review of normal appearances and most common complications[J]. Radiol Med，2019，124(7)：693-703. DOI: 10.1007/s11547-019-01009-9.
[58]
Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri[J]. Int J Gynaecol Obstet，2018，143(Suppl 2)：22-36. DOI: 10.1002/ijgo.12611.
[59]
Cibula D, Pötter R, Planchamp F, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer[J]. Virchows Arch，2018，472(6)：919-936. DOI: 10.1007/s00428-018-2362-9.
[60]
Nobbenhuis MA, Balasubramani L, Kolomainen DF, et al. Surgical management and follow-up of patients with cervical cancer: survey of gynaecological oncologists in the UK[J]. J Obstet Gynaecol，2012，32(6)：576-579. DOI: 10.3109/01443615.2012.694510.
[1]
Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy[J]. Cancer-Am Cancer Soc，1948，1(2)：177-183. DOI: 10.1002/1097-0142(194807)1:2<177::aid-cncr2820010203>3.0.co;2-a.
[2]
Laporte GA, Zanini L, Zanvettor PH, et al. Guidelines of the Brazilian Society of Oncologic Surgery for pelvic exenteration in the treatment of cervical cancer[J]. J Surg Oncol，2020，121(5)：718-729. DOI：10.1002/jso.25759.
[3]
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cervical cancer (version.1 2021)[EB/OL]. (2020-10-02) [2021-03-17].

URL    
[4]
Fotopoulou C, Neumann U, Kraetschell R, et al. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies[J]. J Surg Oncol，2010，101(6)：507-512. DOI: 10.1002/jso.21518.
[5]
Jurado M, Alcázar JL, Martinez-Monge R. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience[J]. Gynecol Oncol，2010，116(1)：38-43. DOI: 10.1016/j.ygyno.2009.09.035.
[6]
Höckel M, Horn L, Einenkel J. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy[J]. Gynecol Oncol，2012，127(2)：297-302. DOI: 10.1016/j.ygyno.2012.07.120.
[7]
Höckel M. Long-term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies[J]. Curr Oncol Rep，2015，17(3)：435. DOI: 10.1007/s11912-014-0435-8.
[8]
Kroon HM, Dudi-Venkata NN, Bedrikovetski S, et al. Palliative pelvic exenteration: a systematic review of patient-centered outcomes[J]. Eur J Surg Oncol，2019，45(10)：1787-1795. DOI: 10.1016/j.ejso.2019.06.011.
[9]
Quyn AJ, Solomon MJ, Lee PM, et al. Palliative pelvic exenteration: clinical outcomes and quality of life[J]. Dis Colon Rectum，2016，59(11)：1005-1010. DOI: 10.1097/DCR.0000000000000679.
[10]
Peiretti M, Zapardiel I, Zanagnolo V, et al. Management of recurrent cervical cancer: a review of the literature[J]. Surg Oncol，2012，21(2)：e59-e66. DOI: 10.1016/j.suronc.2011.12.008.
[11]
Sagebiel TL, Viswanathan C, Patnana M, et al. Overview of the role of imaging in pelvic exenteration[J]. Radiographics，2015，35(4)：1286-1294. DOI: 10.1148/rg.2015140127.
[12]
Schmidt AM, Imesch P, Fink D, et al. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer[J]. Gynecol Oncol，2012，125(3)：604-609. DOI: 10.1016/j.ygyno.2012.03.001.
[13]
Berek JS, Howe C, Lagasse LD, et al. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA[J]. Gynecol Oncol，2005，99(1)：153-159. DOI: 10.1016/j.ygyno.2005.05.034.
[14]
Brown AJ, Shah JS, Fleming ND, et al. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer[J]. Gynecol Oncol，2016，142(2)：283-285. DOI: 10.1016/j.ygyno.2016.05.030.
[15]
刘继红，黄鹤，万挺. 盆腔器官廓清术在复发宫颈癌治疗中的价值[J]. 中国实用妇科与产科杂志，2018，34(11)：1223-1226. DOI: 10.19538/j.fk2018110110.
[16]
Knight S, Lambaudie E, Sabiani L, et al. Pelvic exenterations for gynecologic cancers: a retrospective analysis of a 30-year experience in a cancer center[J]. Eur J Surg Oncol，2018，44(12)：1929-1934. DOI: 10.1016/j.ejso.2018.08.017.
[17]
Diver EJ, Rauh-Hain JA, Del CM. Total pelvic exenteration for gynecologic malignancies[J]. Int J Surg Oncol，2012，2012：693535. DOI: 10.1155/2012/693535.
[18]
Lakhman Y, Nougaret S, Miccò M, et al. Role of MR imaging and FDG PET/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies[J]. Radiographics，2015，35(4)：1295-1313. DOI: 10.1148/rg.2015140313.
[19]
Lyell NJ, Kitano M, Smith B, et al. The effect of preoperative nutritional status on postoperative complications and overall survival in patients undergoing pelvic exenteration: a multi-disciplinary, multi-institutional cohort study[J]. Am J Surg，2019，218(2)：275-280. DOI: 10.1016/j.amjsurg.2019.03.021.
[20]
Köhler C, Tozzi R, Possover M, et al. Explorative laparoscopy prior to exenterative surgery[J]. Gynecol Oncol，2002，86(3)：311-315. DOI: 10.1006/gyno.2002.6764.
[21]
Magrina JF, Stanhope CR, Weaver AL. Pelvic exenterations: supralevator, infralevator, and with vulvectomy[J]. Gynecol Oncol，1997，64(1)：130-135. DOI: 10.1006/gyno.1996.4532.
[22]
Marnitz S, Köhler C, Müller M, et al. Indications for primary and secondary exenterations in patients with cervical cancer[J]. Gynecol Oncol，2006，103(3)：1023-1030. DOI：10.1016/j.ygyno.2006.06.027.
[23]
Yang Q, Tang J. Application of robot-assisted laparoscopic pelvic exenteration in treating gynecologic malignancies[J]. Chinese Med J Peking，2019，132(8)：976-979. DOI: 10.1097/CM9.0000000000000202.
[24]
Kanao H, Aoki Y, Omi M, et al. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: technical feasibility and short-term oncologic outcome[J]. Gynecol Oncol，2021，161(1)：34-38. DOI: 10.1016/j.ygyno.2020.12.034.
[25]
Bizzarri N, Chiantera V, Ercoli A, et al. Minimally invasive pelvic exenteration for gynecologic malignancies: a multi-institutional case series and review of the literature[J]. J Minim Invas Gyn，2019，26(7)：1316-1326. DOI: 10.1016/j.jmig.2018.12.019.
[26]
Goldberg GL, Sukumvanich P, Einstein MH, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center experience (1987 to 2003)[J]. Gynecol Oncol，2006，101(2)：261-268. DOI: 10.1016/j.ygyno.2005.10.011.
[27]
Menahem B, Vallois A, Alves A, et al. Prophylactic pelvic drainage after rectal resection with extraperitoneal anastomosis: is it worthwhile? A Meta-analysis of randomized controlled trials[J]. Int J Colorectal Dis，2017，32(11)：1531-1538. DOI: 10.1007/s00384-017-2891-8.
[28]
Yazici S, Tonyali S, Bozaci AC, et al. Urinary and fecal diversion following pelvic exenteration: comparison of double-barrelled and plain wet colostomy[J]. Urol J，2018，15(5)：290-294. DOI：10.22037/uj.v0i0.4461.
[29]
Li Z, Liu Z, Yao K, et al. An improved ileal conduit surgery for bladder cancer with fewer complications[J]. Cancer Commun，2019，39(1)：19. DOI: 10.1186/s40880-019-0366-8.
[30]
Carter MF, Dalton DP, Garnett JE. Simultaneous diversion of the urinary and fecal streams utilizing a single abdominal stoma: the double-barreled wet colostomy[J]. J Urology，1989，141(5)：1189-1191.DOI: 10.1016/s0022-5347(17)41210-9.
[31]
Bloemendaal AL, Kraus R, Buchs NC, et al. Double-barrelled wet colostomy formation after pelvic exenteration for locally advanced or recurrent rectal cancer[J]. Colorectal Dis，2016，18(11)：O427-O431. DOI: 10.1111/codi.13512.
[32]
Martínez-Gómez C, Angeles MA, Martinez A, et al. Urinary diversion after pelvic exenteration for gynecologic malignancies[J]. Int J Gynecol Cancer，2021，31(1)：1-10. DOI: 10.1136/ijgc-2020-002015.
[33]
Qu LG, Lawrentschuk N. Orthotopic neobladder reconstruction: patient selection and perspectives[J]. Res Rep Urol, 2019，11：333-341. DOI: 10.2147/RRU.S181473.
[34]
Penalver MA, Bejany DE, Averette HE, et al. Continent urinary diversion in gynecologic oncology[J]. Int J Gynecol Obstet，1990，34(3)：274-288. DOI：10.1016/0090-8258(89)90159-5.
[35]
Salom EM, Mendez LE, Schey D, et al. Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years[J]. Am J Obstet Gynecol，2004，190(4)：994-1003. DOI: 10.1016/j.ajog.2004.01.023.
[36]
Davis NF, Burke JP, Mcdermott T, et al. Bricker versus Wallace anastomosis: a Meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion[J]．Can Urol Assoc J，2015，9(5-6)：E284-E290. DOI: 10.5489/cuaj.2692.
[37]
Siddiqui KM, Izawa JI. Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy[J]. World J Urol，2016，34(1)：19-24. DOI: 10.1007/s00345-015-1706-1.
[38]
Le Duc A, Camey M, Teillac P. An original antireflux ureteroileal implantation technique: long-term followup[J]. J Urol，1987，137(6)：1156-1158. DOI: 10.1016/s0022-5347(17)44433-8.
[39]
Hu W, Su B, Xiao B, et al. Simultaneous antegrade and retrograde endoscopic treatment of non-malignant ureterointestinal anastomotic strictures following urinary diversion[J]. Bmc Urol，2017，17(1)：61. DOI: 10.1186/s12894-017-0252-0.
[40]
Gin GE, Ruel NH, Parihar JS, et al. Ureteroenteric anastomotic revision as initial management of stricture after urinary diversion[J]. Int J Urol，2017，24(5)：390-395. DOI: 10.1111/iju.13323.
[41]
Moraru DC, Scripcariu V. Decisional algorithms for the reconstruction of pelviperineal defects after total pelvic exenteration: a review[J]. J Chirurgie，2018，14(1)：17-22.DOI: 10.7438/1584-9341-14-1-3.
[42]
Kaartinen IS, Vuento MH, Hyöty MK, et al. Reconstruction of the pelvic floor and the vagina after total pelvic exenteration using the transverse musculocutaneous gracilis flap[J]. J Plast Reconstr Aesthet Surg，2015，68(1)：93-97. DOI: 10.1016/j.bjps.2014.08.059.
[43]
Cortinovis U, Sala L, Bonomi S, et al. Rectus abdominis myofascial flap for vaginal reconstruction after pelvic exenteration[J]. Ann Plas Surg，2018，81(5)：576-583. DOI：10.1097/SAP.0000000000001578.
[44]
Pommergaard HC, Gessler B, Burcharth J, et al. Preoperative risk factors for anastomotic leakage after resection for colorectal cancer: a systematic review and Meta-analysis[J]. Colorectal Dis，2014，16(9)：662-671. DOI: 10.1111/codi.12618.
[45]
Neutzling CB, Lustosa SA, Proenca IM, et al. Stapled versus handsewn methods for colorectal anastomosis surgery[J]. Cochrane Database Syst Rev，2012(2)：CD003144. DOI: 10.1002/14651858.CD003144.pub2.
[46]
Gu WL, Wu SW. Meta-analysis of defunctioning stoma in low anterior resection with total mesorectal excision for rectal cancer: evidence based on thirteen studies[J]. World J Surg Oncol，2015，13(1)：9. DOI: 10.1186/s12957-014-0417-1.
[47]
Zhou X, Wang B, Li F, et al. Risk factors associated with nonclosure of defunctioning stomas after sphincter-preserving low anterior resection of rectal cancer: a Meta-analysis[J]. Dis Colon Rectum，2017，60(5)：544-554. DOI: 10.1097/DCR.0000000000000819.
[48]
Lago V, Fotopoulou C, Chiantera V, et al. Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: a multi-centre study[J]. Gynecol Oncol，2019，153(3)：549-554. DOI: 10.1016/j.ygyno.2019.03.241.
[49]
Sparreboom CL, van Groningen JT, Lingsma HF, et al. Different risk factors for early and late colorectal anastomotic leakage in a nationwide audit[J]. Dis Colon Rectum，2018，61(11)：1258-1266. DOI: 10.1097/DCR.0000000000001202.
[50]
Yin TC, Tsai HL, Yang PF, et al. Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer[J]. World J Surg Oncol，2017，15(1)：80. DOI: 10.1186/s12957-017-1149-9.
[1] 夏效泳, 王立超, 朱治国, 丛云海, 史宗新. 深度塌陷性胫骨平台骨折的形态特点和治疗策略[J]. 中华关节外科杂志(电子版), 2023, 17(05): 625-632.
[2] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[5] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[6] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[9] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[10] 陈俊宇, 崔宇. TAPP治疗腹股沟嵌顿疝的临床分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 546-549.
[11] 赵新亮, 荆克杰, 樊红艳, 王妮, 葸根. 腹腔镜完全腹膜外补片与腹腔内补片治疗两侧下腹壁切口疝的临床对比观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 554-557.
[12] 惠立良, 王成果, 段东峰, 王健. 腹腔镜保留脾脏胰体尾切除术治疗胰体尾部良性肿瘤及部分交界性肿瘤的临床效果[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 558-561.
[13] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[14] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[15] 朴成林, 蓝炘, 司振铎, 冯健, 安峰铎, 李强, 谈明坤, 赵娜, 冷建军. 局部晚期右半结肠癌行结肠癌根治联合胰十二指肠切除术疗效分析：附5例报告[J]. 中华临床医师杂志(电子版), 2023, 17(06): 666-670.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号